description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGGACAAACCAGGAGAGACCCAAGTGATTTCATATGAAATGCTTCATGTCACACCTCCAATGAGCCCACCAGATGTCCTCAAGACCAGTCCTGTGGCTGATGCTGCTGGTTGGGTGGATGTGGATAAAGAAACTCTGCAACACAGGAGGTACCCAAATGTGTTTGGGATTGGGGACTGCACCAACCTTCCTACGTCAAAGACCGCTGCTGCAGTAGCTGCCCAGTCAGGAATACTTGATAGGACAATTTCTGTAATTATGAAGAATCAAACACCAACAAAGAAGTATGATGGCTACACATCATGTCCACTGGTGACCGGCTACAACCGTGTGATTCTTGCTGAGTTTGACTACAAAGCAGAGCCGCTAGAAACCTTCCCCTTTGATCAAAGCAAAGAGCGCCTTTCCATGTATCTCATGAAAGCTGACCTGATGCCTTTCCTGTATTGGAATATGATGCTAAGGGGTTACTGGGGAG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... SQRDL(58472)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Jesus Prieto-Lloret et al.
American journal of physiology. Lung cellular and molecular physiology, 314(4), L670-L685 (2018-01-20)
Application of H2S ("sulfide") elicits a complex contraction in rat pulmonary arteries (PAs) comprising a small transient contraction (phase 1; Ph1) followed by relaxation and then a second, larger, and more sustained contraction (phase 2; Ph2). We investigated the mechanisms
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU032561-50UG | 04061828346196 |
| EHU032561-20UG | 04061828581092 |